Outcome of board meeting of Medicamen Biotech

Held on 21 June 2017

Medicamen Biotech announced that the Board of Directors at its meeting held on 21 June 2017 has approved the following -

Approval to the Issue & Allot 306000 Warrants, convertible into Equity Shares of the Company at a price of Rs. 543/- per warrant (including a premium of Rs.533/- each), in accordance with the SEBI (ICDR) Regulations, 2009 on Preferential Allotment basis to a promoter group and non promoter group/ Investors.

Calling of an Extraordinary General Meeting, of the Company in relation to the Preferential Issue as aforesaid on 17 July, 2017.

Powered by Capital Market - Live News